Resonance Speci. — 360° view

Resonance Speci, a company in the Specialty Chemicals industry, reported revenue of ₹34 crore and net profit of ₹8.47 crore for the September 2026 quarter.

Resonance Speci. (BSE: RESONANCE) closed at ₹262.50 on 20 Nov 2026, up 172.8% over the past year. Its market capitalisation is ₹303 crore and it trades at 14.2 times earnings.

Share price
₹262.50 (20 Nov 2026)
Market cap
₹303 Cr (20 Nov 2026)
P/E
14.21 (20 Nov 2026)
Revenue
₹34 Cr (September 2026 quarter)
Net profit
₹8 Cr (September 2026 quarter)
ROCE
20.0% (FY26)
ROE
15.0% (FY26)
Book value
₹74.7 (FY26)
Dividend yield
0.38% (FY26)
52-week high / low
₹323.20 / ₹77.00 (20 Nov 2026)
1-year return
172.8% (to 20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
BSE: RESONANCE

Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.